Treat-to-Target in Inflammatory Bowel Diseases, What Is the Target and How Do We Treat?

Area of Science:

• Gastroenterology
• Immunology
• Internal Medicine

Background:

• Inflammatory bowel diseases (IBD), including Crohn disease (CD) and ulcerative colitis (UC), are chronic gastrointestinal disorders.
• These immune-mediated conditions can lead to progressive, long-term complications if not managed effectively.

Purpose of the Study:

• To review the treat-to-target (T2T) guidance for IBD management.
• To discuss new evidence on therapeutic targets in CD and UC.
• To evaluate the real-world application of the T2T approach in IBD.

Main Methods:

• Literature review of T2T guidance and recent studies on IBD targets.
• Analysis of evidence supporting various treatment targets in CD and UC.
• Discussion of practical implementation challenges and successes of T2T.

Main Results:

• The Selecting Therapeutic Targets in Inflammatory Bowel Disease (STIBD) committee developed T2T guidelines.
• Emerging evidence highlights the role of specific targets in achieving treatment goals for CD and UC.
• Real-world data suggests T2T is applicable but requires careful monitoring and adaptation.

Conclusions:

• The T2T approach is critical for optimizing IBD therapy and preventing adverse outcomes.
• Adherence to T2T guidance can improve patient management and long-term prognosis in CD and UC.
• Further research and clinical experience are needed to refine T2T strategies for IBD.